Copyright © 2011 M.J. Powers & Company Publishers. All rights reserved
HomeProductsContinuing EducationSubscriber Services

Contact UsPsychiatry Drug AlertsPsychiatry Alerts NOSChild & Adol Psy AlertsPrimaryCare Drug Alerts

Psychiatry Drug Alerts
​A guide to evidence-based practice on the best ways to: 

  • Provide optimum pharmacotherapy for psychiatric disorders.
  • Recognize, avoid, and manage psychiatric drug side effects and psychiatric drug interactions.
  • Recognize psychiatric consequences of drugs used in other areas of medicine.

You'll find well-written, easy to read updates from a diverse selection of journals. 
To give you an idea of what you can expect, here's a selection of titles from past issues . . .

Cardiovascular Safety of Escitalopram
Review: Lamotrigine in Psychiatry
Antidepressants and Postpartum Hemorrhage
Adjunctive Aripiprazole for Chronic/Recurrent Depression
Acute Neural Effects of Antidepressants
Mefloquine Neuropsychiatric Warning Strengthened
Zonisamide for Bulimia Nervosa
Multiple Effects of Pravastatin-Paroxetine Co-Medication

Psychiatry Drug Alerts is an 8-page monthly update on the efficacy and safety of psychiatric drugs. The ALERTS in Psychiatry Drug Alerts are summaries, from a variety of journals, that can help you solve a problem, warn you about safety, or reassure you about efficacy. You can be assured that Psychiatry Drug Alerts is timely and thorough. We screen over 20,000 citations per week. You can also be assured of objectivity because Psychiatry Drug Alerts is independent. There is no sponsorship or advertisers of any kind associated with Psychiatry Drug Alerts. In fact we call special attention to manufacturer-sponsored studies.